Difference between revisions of "Clinical decision support or genetically guided personalized medicine: a systematic review"

From Clinfowiki
Jump to: navigation, search
m (Week 7 changes)
 
Line 3: Line 3:
 
===Background===
 
===Background===
  
Genetically guided personalized medicine or (GPM) is currently undergoing a growing pain as does with any new advancement in medicine or technology and more-so when both come together.  As technology advances the demand becomes greater. Among the 3,000 board certified geneticists of which 1,200 reside in the USA there are approximately 2,500 clinical genetic tests performed and as it grows it will become unreasonable to ask clinicians to remember every possible specific testing.  However, with the use of health information technology it has the potential to overcome those problems and explore the positive outcomes of GPM.<ref name="Welch 2012"></ref>
+
Genetically guided personalized medicine (GPM) is currently undergoing growing pains as does any new advancement in medicine or technology and more so when both come together.  As technology in genetics advances, the demand for genetic information becomes greater. Among the 3,000 board certified geneticists, 1200 reside in the US. There are approximately 2,500 genetic tests available for clinical use, and as this number grows, it will become unreasonable to ask clinicians to remember every possible test.  However, health information technology has the potential to overcome those problems and help create positive outcomes of GPM.<ref name="Welch 2012"></ref>
  
  
Line 12: Line 12:
  
 
===Summary Findings===
 
===Summary Findings===
Researchers found that through this process, many CDS were stand alone and many also shifted to an integrated CDS systems.  Though CDS and GPM is still in its infancy, many are seeing the promise that it has to offer.  Only few facilities have this integration they are seeing the positive impact it has shown promise of growth, research, and many new findings.<ref name="Welch 2012"></ref>
+
Researchers found that through this process, many CDS were stand alone and many also shifted to an integrated CDS system.  Though CDS and GPM are still in their infancy, many are seeing the promise that the two have to offer.  Only a few facilities have this integration, but they are seeing the positive impact; it has shown promise of growth, research, and many new findings.<ref name="Welch 2012"></ref>
  
 
===Comments===  
 
===Comments===  

Latest revision as of 02:25, 12 March 2015

"To review literature on clinical decision support (CDS) for genetically guided personalized medicine(GPM)"[1]

Background

Genetically guided personalized medicine (GPM) is currently undergoing growing pains as does any new advancement in medicine or technology and more so when both come together. As technology in genetics advances, the demand for genetic information becomes greater. Among the 3,000 board certified geneticists, 1200 reside in the US. There are approximately 2,500 genetic tests available for clinical use, and as this number grows, it will become unreasonable to ask clinicians to remember every possible test. However, health information technology has the potential to overcome those problems and help create positive outcomes of GPM.[1]


Methods

Research began by gathering articles from "1990-2011 using a search strategy adapted from previous systematic reviews of CDS and genetic health services"[1] Articles had to meet inclusion criteria of the potential 3416 articles only 37 met full criteria and of those 37 majority were published on or after 2007. These articles focused on CDS systems for genetically guided cancer management and within those they did have more specific type of cancer i.e. breast, colon, and some focused on family history of cancer.

Summary Findings

Researchers found that through this process, many CDS were stand alone and many also shifted to an integrated CDS system. Though CDS and GPM are still in their infancy, many are seeing the promise that the two have to offer. Only a few facilities have this integration, but they are seeing the positive impact; it has shown promise of growth, research, and many new findings.[1]

Comments

If this is a growing field, I'm curious as to how both CDS and GPM come together to produce alerts, and how can this be done on a select patients. Does the system they are working with have the capability of being highly selective and only alert in that particular setting? Medicine and it's ever changing findings and discoveries never ceases to amaze me and I realize how much left there is to learn.

References

  1. 1.0 1.1 1.2 1.3 Welch BM, Kawamoto K, 22August2012, Clinical decision support for genetically guided personalized medicine: a systematic review, J AM Med Inform Assoc,2013,29:388-400,http://jamia.oxfordjournals.org/content/20/2/388